66
Views
6
CrossRef citations to date
0
Altmetric
Original Article

eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment

, MD, , , , , , , & show all
Pages 548-554 | Received 20 Jul 2009, Accepted 14 Sep 2009, Published online: 05 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cezar Kayzuka Cotta Filho, Gustavo Henrique Oliveira-Paula, Vitória Carolina Rondon Pereira & Riccardo Lacchini. (2020) Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 927-951.
Read now

Articles from other publishers (5)

T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro & A. V. Kapytski. (2023) Association of polymorphic variants of <i>CYP2C19</i>, <i>P2RY12</i>, <i>ITGB3</i>, <i>ITGA2</i> and <i>eNOS3</i> genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction. Rational Pharmacotherapy in Cardiology 19:3, pages 222-229.
Crossref
Teresa Strisciuglio, Giuseppe Di Gioia, Chiara De Biase, Massimiliano Esposito, Danilo Franco, Bruno Trimarco & Emanuele Barbato. (2015) Genetically Determined Platelet Reactivity and Related Clinical Implications. High Blood Pressure & Cardiovascular Prevention 22:3, pages 257-264.
Crossref
Yamin Liu, Wenjing Luo, Huan Yang, Wei Fang, Tao Xi, Yunman Li & Jing Xiong. (2015) Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp). Thrombosis Research 136:2, pages 319-327.
Crossref
Hong-Guang Xie & Ying-Dong Zhang. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 469 506 .
Hong-Guang Xie, Jian-Jun Zou, Zuo-Ying Hu, Jun-Jie Zhang, Fei Ye & Shao-Liang Chen. (2011) Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond. Pharmacology & Therapeutics 129:3, pages 267-289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.